Skip to content

Spinal Cord Stimulation Therapy for Gait and Postural Disturbance in Patients With Parkinson's Disease

The Study of Spinal Cord Stimulation Therapy for Gait and Postural Disturbance in Patients With Parkinson's Disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024326
Enrollment
Unknown
Registered
2019-07-06
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Stimulation on T8-9:Spinal Cord Stimulation (30Hz, 60Hz, 130Hz)
Stimulation on T9-10:Spinal Cord Stimulation (30Hz, 60Hz, 130Hz)

Sponsors

Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated with Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age between 40 to 70 years old 2) Idiopathic Parkinson's disease, Hoehn & Yahr stage (medication on condition) at 2~4; 3) Patients badly suffered from gait or postural problems(Gait and Fall Questionnaire > 32 points); 4) Spinal Cord Stimulation eligibility has been confirmed by neurologist and neurosurgeon; 5) Patients willingly seek surgical treatment for gait and postural disturbance of Parkinson's disease; 6) Ability to perform a gait/walking task (under close supervision); 7) No history of other neurological or psychologic disorders; 8) Informed consent and have good compliance.

Exclusion criteria

Exclusion criteria: 1) Lesion in spinal cord or other surgical contraindications; 2) Haven't achieved the optimal therapeutic effects of Deep Brain Stimulation surgery or drug therapy; 3) Medical history of stroke, amyotrophic lateral sclerosis or myasthenia gravis; 4) Taking prohibited medications (such as lithium, valproate, steroids, adrenergic agonists, etc.); 5) Severe depression (Beck Depression Inventory scores # 25) or dementia(Mini Mental State Examination < 24); 6) Cardiac, renal or other important organs hypofunction or dysfunction, or unstable vital signs, women reporting that they are pregnant; 7) Any situation (medical, psychological, social, geographical, etc.) that may endanger patient's life or result in patients withdrawing from the study at present or in the future; 8) Paitents with poor treatment compliance.

Design outcomes

Primary

MeasureTime frame
Timed Up and go Test, TUG;rapid 360 degree rotation;6 minutes walking test;Dual Task, DT;angle of anterior thoracolumbar flexion and lateral trunk flexion;

Secondary

MeasureTime frame
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale Part-III, UPDRS-III;Gait and Fall Questionnaire, GFQ;Berg Balance scale, BBS;8-item Parkinson’s Disease Questionnaire, PDQ-8;EuroQol-5 Dimensions, EQ-5D;Non-motor symtoms Qustionnaire, NMS-Quest;17-item Hamilton Depression Scale,HAMD-17;14-item Hamilton anxiety scale, HAMA-14;Scales for Outcomes in Parkinson's Disease-Autonomic questionnaire, SCOPA-AUT;Pain assessment scales;

Countries

China

Contacts

Public ContactJun Liu

Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated with Shanghai Jiaotong University School of Medicine

jly0520@hotmail.com+86 15221303819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026